Abstract Despite hypothesized concerns about deterioration beginning in adolescence, longitudinal data and associated factors regarding standardized assessment of physical functioning are not available for Fontan patients. Parents who participated in the Fontan Cross-Sectional Study completed the Child Health Questionnaire at 2 time points for 245 subjects ages 6-18 years. Associations between change in Physical Functioning Summary Score and baseline patient, medical, and laboratory characteristics (mean age 9.5 ± 1.7 years) and follow-up patient and medical characteristics (mean age 16.2 ± 1.6 years) were determined by regression analyses. During a mean of 6.7 ± 0.4 years, a small (not clinically important) but statistically significant decrease in score from 46.2 ± 11.7 to 44.5 ± 12.1 (p \ 0.03) was noted. Subjects with higher baseline scores had a greater decrease in score (r = -0.48; p \ 0.001). A multivariable model of patient and medical characteristics (R 2 = 0.11) showed that a greater decrease in score was significantly associated with interim development of asthma (n = 13; parameter estimate [PE] -6.6; p \ 0.05) or other chronic respiratory, lung, or breathing problems (n = 13; PE -12.5; p \ 0.001) and the presence of protein-losing enteropathy at any time (n = 12; PE -9.4; p = 0.006). Change in score was not significantly associated with baseline laboratory measures of exercise capacity and ventricular characteristics and function. Therefore, although physical functioning may be stable during adolescence for many Fontan patients, deterioration occurs in some in association with respiratory conditions and protein-losing enteropathy. Further longitudinal study is necessary to better understand the relationship between clinical morbidities and functional health status as these patients transition into adulthood.
Introduction
Patients with functional single ventricle who have had the Fontan procedure are at risk for important morbidities and functional deterioration [9, 10, 30] . Cross-sectional studies performed in this population at various ages have shown some decrements in physical functioning relative to the normal population and have identified various associated patient and medical characteristics [22, 31] . Nonetheless, the proportion of the variation in functional health status explained by these factors has been low, and a paucity of longitudinal data are available [24, 26] . Issues regarding accurate conceptualization and assessment of quality of life and functional health status in congenital heart disease populations may limit interpretation of available studies [27] . There are concerns that functional deterioration may be accelerated in adolescence and early adulthood, an observation largely based on clinic populations for which the denominator is not well-characterized, rigorous assessment of physical functioning was not performed, or longitudinal data were lacking [38] .
The Pediatric Heart Network Fontan Cross-Sectional Study (Fontan 1) characterized a multiinstitutional cohort of survivors after the Fontan procedure with an age at enrollment of 6-18 years [2, 36] . Cross-sectional assessment included completion of functional health status questionnaires. We have performed a second cross-sectional assessment of this cohort that was limited to collection of clinical events and measurement of functional health status (Fontan 2). The primary objectives of this analysis were to characterize changes in parent-reported physical functioning through adolescence and to identify associated patient and medical factors.
Methods

Study Design and Subjects
The methods for Fontan 1 have been previously described [36] . The current study is an additional cross-sectional assessment of eligible participants from Fontan 1 and was approved by the Institutional Review Board at each center. Medical records and death registries were screened first to identify patients who were alive and who had not had cardiac transplantation or conversion to a biventricular circulation. Eligible patients were then approached for participation in the current cross-sectional assessment (Fontan 2), and written informed consent and assent, as appropriate, were obtained for each subject. Enrollment occurred from November 2009 to May 2011.
Enrollment and Data Collection
Data were abstracted into standardized forms from medical record review and included updated anatomic, clinical, and procedural details since Fontan 1. In addition, current clinical state (height, weight, New York Heart Association [NYHA] heart failure class) and socioeconomic status (Hollingshead Index of Social Status; linkage to United States census data by patient address) were obtained from structured interviews performed by telephone or in person with the parent/guardian or patient (depending on the age of the patient).
Health-Related Quality of Life Questionnaire
At Fontan 1, when participants were 6-18 years of age, the parent/guardian completed the Child Health Questionnaire (CHQ) Parent Form (PF50). This questionnaire is normed and validated for children ages 5-18 years as reported in previous publications from Fontan 1 [19, 24, 26] . At Fontan 2, some of the cohort were now 19 years of age and older, and the parent report form of the CHQ no longer applied. Because it was essential to compare scores from identical questionnaires, the study population for the current analysis was restricted to those \19 years of age at Fontan 2 and whose parents completed the CHQ PF50 at both time points either by mail or inperson at the time of a routinely scheduled clinic visit [20] .
The CHQ PF50 produces scores for 14 domains and 2 summary scores (physical functioning and psychosocial functioning) calculated from responses. The CHQ also contains a checklist of medical conditions. Data from a normative population of 379 children in the United States are available for comparison [20] . Greater scores indicate better functioning, and from the normative sample, a 5-to 10-point difference in the summary score represents a clinically meaningful difference.
Data Analysis
Participants whose parent/guardian completed the CHQ at both Fontan 1 and 2 and had sufficiently completed the questionnaires to allow for calculation of the physical functioning summary score at both time points were included in the analysis. To determine potential bias in the studied population, the characteristics of eligible subjects who participated in Fontan 2 were compared with those who participated in Fontan 1 but not Fontan 2 (analysis of variance, Fisher's exact test, Wilcoxon rank-sum test, or KruskallWallis test for unadjusted comparisons; Mantel-Haenszel test for linear trend, regression models for age-adjusted comparisons). The change in the physical functioning summary score was assessed using paired Student's t test. Associations between patient, medical, and laboratory testing characteristics and the change in score were determined using linear regression. Bivariable associations and testing for linearity using generalized additive models were first performed for each characteristic. Appropriate variable transformations were explored and applied if nonlinearity was significant. Separate stepwise multiple regression analyses were performed for subgroups of characteristics, including interim clinical events and changes in medical conditions between Fontan 1 and 2. Mean imputation (replacement of missing values with the mean of all nonmissing values) was used to impute missing values for characteristics before performing multiple regression for analysis of echocardiographic variables only; \2 % of values were missing for any given echocardiographic variable. Variable entry and stay significance levels were specified at p = 0.15 and p = 0.05, respectively. Bootstrap resampling was used to determine variable reliability for model selection. The proportion of variance explained by the model was assessed using R 2 and R 2 -adjusted values, which was adjusted downward to account for the effect of increasing R 2 due to high variable counts. A final multivariable model was determined for patient and medical characteristics, but not for laboratory testing variables from Fontan 1, because not all subjects underwent all of the tests or had all of the prespecified data [26] . All analyses were performed using SAS statistical software version 9.2 (SAS, Cary, NC). 
Results
Participation
Of the 546 subjects who participated in Fontan 1, 30 were not eligible for Fontan 2 (1 conversion to biventricular repair, 16 deaths, 11 heart transplantations, and 2 who were transplanted and died). Of 516 eligible subjects for Fontan 2, 315 were \19 years of age, 42 of whom declined participation or were lost to follow-up. Of those 273 subjects who consented for Fontan 2, 28 had no or insufficient data to derive the physical functioning summary score from the CHQ-PF50 from at least 1 of the 2 time points (14 for Fontan 1 only, 12 for Fontan 2 only, and 2 for both). Thus, paired data from Fontan 1 and 2 for the summary score were available for 245 subjects who comprise the study sample for the current analysis. Figure 1 gives the number of these subjects who had each element of the laboratory testing from Fontan 1.
Participation Bias
The patient characteristics and laboratory testing results from Fontan 1 for these 245 Fontan 2 participants were compared with the 70 subjects \19 years of age who were eligible but declined to participate in Fontan 2, who were lost to follow-up (n = 42), or who consented for Fontan 2 participation but did not have CHQ summary scores for both Fontan 1 and 2 (n = 28) (Supplementary Table S1 ). Participants were significantly more likely to be of white race and less likely to identify as ''other'' (neither black nor white) race. Participants had higher household income, higher level of maternal education, and higher psychosocial functioning summary scores from Fontan 1 but similar physical functioning summary scores. No significant differences between participants and nonparticipants were identified in any cardiac characteristics or laboratory measures from Fontan 1.
Patient Characteristics
The mean age at enrollment was 9.5 ± 1.7 years for Fontan 1 and 16.2 ± 1.6 years at Fontan 2; 59 % of subjects were male. Ventricular morphology was left for 47 %, right 37 %, and mixed for 16 %. A staging superior cavopulmonary anastomosis had been performed for 90 %. The mean age at Fontan procedure was 2.9 ± 1.2 years with 76 % having an atrial level fenestration. The type of Fontan connection was atriopulmonary for 4 %, intracardiac lateral tunnel for 59 %, extracardiac conduit for 35 %, and other connection type for 2 %.
Change in Physical Functioning Summary Score
The mean score at Fontan 1 was 46.2 ± 11.7 and at Fontan 2 was 44.5 ± 12.1 for a mean change of -1.7 ± 11.9 (25th percentile -0.9; 75th percentile ?4.5; p \ 0.03). The mean time interval between Fontan 1 and 2 was 6.7 ± 0.4 years. A slope of yearly change in score showed a mean decrease of -0.3 ± 1.8 per year. Scores at Fontan 1 and 2 showed a positive linear correlation (r = 0.50; p \ 0.001). There was no significant association between the change in score and the time interval between Fontan 1 and 2. Overall, a higher score at Fontan 1 was negatively associated with change in score (parameter estimate [PE] -0.49; p \ 0.001), with those having higher scores at Fontan 1 showing a greater decrease, whereas those with lower scores at Fontan 1 showed a greater increase in score at Fontan 2. This likely represents some regression to the mean. The parent or guardian who completed the CHQ at Fontan 2 (88 % female) was the same person as for Fontan 1 (84 % females) for 206 (84 %) participants with no association with change in score.
Association of Change in Score With Patient Characteristics From Fontan 1
In bivariable analyses, worsening of physical functioning summary score was significantly associated with higher score at Fontan 1 (PE -0.5; p \ 0.001) and both white race and black race (PE -3.8, -8.8, respectively; p = 0.02) relative to ''other'' race. Change in score was not significantly associated with sex, ventricular morphology, staging with a superior cavopulmonary connection, fenestration, type of Fontan connection, age at Fontan 1, or z-score of body mass index at Fontan 1. Only score at Fontan 1 was significant in multivariable modeling ( Table 1) .
Association of Change in Score With Socioeconomic Characteristics at Fontan 2
Worsening score was significantly associated with maternal education beyond some high school (without a gradient with higher category) but not with household income. However, neither socioeconomic status variable had sufficient bootstrap reliability in multivariable modeling.
Association of Change in Score With Baseline Medical History Events Before Fontan 1
In bivariable analyses, subsequent worsening of score was significantly associated with the presence of protein-losing enteropathy (PE -19.8; p \ 0.001; however, it was present in only five current participants at Fontan 1). Worsening of score was not associated with the presence of stroke, seizure (p = 0.06), thrombosis, or arrhythmia. The presence of other important complications (heterogenous and low-frequency complications) at or before Fontan 1 was also associated with worsening score (PE -4.0; p = 0.03). There was no significant association between change in score and cardiac surgical or catheter intervention procedures at or before Fontan 1. Multivariable modeling showed protein-losing enteropathy at or before Fontan 1 to be significantly associated with worsening score (Table 1) .
Association of Change in Score with Noncardiac Medical Conditions Reported at Fontan 1
For parent-reported medical conditions at Fontan 1, the presence of chronic respiratory, lung, or breathing problems other than asthma (n = 20) was significantly associated in both bivariable and multivariable analyses with an improvement in score, although the proportion of variance explained was small (Table 1) .Change in score was not significantly associated with the following medical conditions present at Fontan 1: asthma, chronic allergies or sinus trouble, chronic orthopedic, bone or joint problems, chronic rheumatic disease, diabetes, epilepsy/seizure disorder, hearing impairment or deafness, speech problems, vision problems, developmental delay or mental retardation, anxiety problems, attention problems, learning problems, behavioral problems, depression, sleep disturbance, or other chronic medical condition. The prevalence of these conditions at Fontan 1 has been previously reported [24] .
Association of Change in Score With Interim Medical History Events Between Fontan 1 and 2
For Fontan 2, data regarding interim medical history events between Fontan 1 and 2 were recorded. An exception was made for cirrhosis, plastic bronchitis, and protein-losing enteropathy to include onset before Fontan 1 because these conditions uniformly persisted in the interim and hence were combined with new occurrences. In bivariable analyses, the interim development of arrhythmia (29 subjects; PE -8.8; p \ 0.001) and the development of protein-losing enteropathy at any time point (13 subjects; PE -10.3; p = 0.002) were significantly associated with worsening score. There was no significant association with interim cardiac surgical or catheter intervention procedures (including pacemaker insertion) or other complications (no strokes, 3 subjects with seizure, 5 with thrombosis, 5 with cirrhosis, 1 with plastic bronchitis, 79 with other heterogeneous and low-frequency important complications). Both interim development of arrhythmia and the development of Because the distribution of brain natriuretic peptide (BNP) levels was skewed, a normalizing logarthimic transformation was used in analyses. Log-BNP from Fontan 1 (n = 228 of Fontan 2 participants) was not significantly associated with change in score (p = 0.60) even after adjusting for age and sex.
Factors Associated With Change in Score Adjusted for Baseline Score at Fontan 1
Given the observation of greater decrease in physical functioning score with higher baseline score at Fontan 1, further regression analysis was explored adjusting for baseline score. A multivariable model for decrease in score was explored that considered for inclusion all previously described patient and parent characteristics as well as medical events and conditions (laboratory testing variables were not considered because few subjects had all tests). This model (n = 200, adjusted R 2 = 0.47) included higher baseline score at Fontan 1 (PE -0.71; p \ 0.001; reliability 100 %); presence of chronic orthopedic, bone, or joint problems at Fontan 1 (n = 14; PE -9.76; p \ 0.001; reliability 50 %); presence of seizure (n = 7; PE -8.77; p = 0.02; reliability 51 %) or arrhythmia at any time before Fontan 2 (n = 41; PE -7.32; p \ 0.001; reliability 89 %); interim development of asthma (n = 12; PE -5.77; p = 0.04; reliability 63 %) or nonasthma chronic respiratory, lung, or breathing problems between Fontan 1 and 2 (n = 12; PE -10.36; p \ 0.001; reliability 75 %), and lower category of household income at Fontan 1 (p \ 0.001; reliability 75 %). Adjustment for baseline score at Fontan 1 did not change the lack of association between change in score and laboratory measures from Fontan 1. Protein-losing enteropathy was not retained in this model adjusted for baseline score. Nonetheless, the score for these participants decreased from 46.8 ± 8.2 at Fontan 1 to 35.3 ± 15.6 at Fontan 2.
Discussion
Summary
We noted a small (not clinically important) but statistically significant decrease in mean physical functioning summary score in a cohort of adolescent Fontan subjects during a mean period of 6.7 ± 0.4 years. Subjects with a higher baseline score from Fontan 1 had a greater decrease in score. A decrease in score was independently associated with both cardiac and noncardiac medical conditions, specifically respiratory conditions, seizure, arrhythmia, and protein-losing enteropathy. There were no significant associations with baseline laboratory measures of exercise capacity and ventricular characteristics and function in subsets of subjects who had undergone this testing at Fontan 1.
Functional Health Status
Subjects after Fontan procedure are at risk for important morbidity and physiologic limitations that may impact both physical and psychosocial aspects of functioning. We previously showed that Fontan subjects not only have lower physical functioning compared with their normal peers but also lower compared with other populations with cardiac and other chronic diseases [24] . This observation has also been reported in other studies and with other assessment measures [22, 23] . Factors associated with poorer physical functioning in this population are not completely understood. Some associations with objective measures of exercise capacity have been reported [25, 26] . Indicators of lower socioeconomic status, presence of noncardiac medical conditions, current medications, and some Fontan characteristics were noted to be associated factors in our previous report of the Fontan 1 study [24] . Exercise capacity and levels of daily physical activity have been shown to deteriorate through adolescence in Fontan subjects [15, 25, 29] . There is also believed to be an accelerating risk of cardiac complications [8, 11, 17] as well as Fontan ''failure'' into adulthood contributing to mortality and necessitating cardiac transplantation. Given the lack of rigorous, longitudinal assessment of functional health status, the rate of decrease and associated factors are poorly understood. This limits the ability to prognosticate and potentially prevent and reverse decreasing physical functioning.
Respiratory Conditions
We noted a clinically important deterioration in physical functioning summary score with the interim development of chronic respiratory, lung, or breathing problems other than asthma. In an analysis of Fontan 1 data, noncardiac conditions, specifically those that were more likely to cause symptoms or limitations on a frequent basis and with greater immediacy, showed greater cross-sectional associations with decreased physical functioning scores [24] . Respiratory conditions could be so characterized, and both asthma and nonasthma respiratory problems were noted in the analysis of Fontan 1 to have a cross-sectional association with lower physical functioning summary score, although they did not seem to be more prevalent than in a normative population [24] . In addition, although not previously reported, respiratory conditions may have a greater adverse impact on patients with Fontan physiology. Chronic respiratory inflammation may be associated with increased systemic arterial stiffness, thus adversely affecting ventricular mechanics and remodeling [1, 3, 40] . Increases in airway and intrathoracic pressure may impede venous return and increase pulmonary vascular resistance (most evident with sleep-disordered breathing), increasing Fontan circuit pressures [34, 39] . Chronic respiratory conditions may also limit physical activity and predispose to obesity, which is associated with adverse ventricular remodeling [4] . Recent studies have suggested a role for pulmonary vasodilators for improving or preventing decrease in exercise capacity and improving ventricular mechanics [12, 13, 28] .
Arrhythmia
The presence and development of arrhythmia was associated with a significant decrease in physical functioning score. Few data are available regarding functional health status in the setting of pediatric arrhythmia, although specific assessment instruments are being developed [32] . Our data are consistent with the findings of the few published studies in this area. Li et al. [21] showed important decreases in exercise tolerance for adults with congenital heart disease who developed atrial flutter. Strieper et al. [37] noted an improvement in quality-of-life scores for children without structural heart disease who had ablation for supraventricular tachycardia. Patients with implanted defibrillators have been shown to have worse physical and psychosocial functioning than patients after Fontan procedure or with other cardiac conditions [5, 7, 18, 24] . Hiramatsu et al. [14] noted an improvement in NYHA functional class after Fontan conversion with arrhythmia surgery and pacemaker therapy. An analysis of Fontan 1 data showed that patients who had pacemaker placement had lower physical functioning summary scores, although this was not associated with change in score in the current analysis [41] .
Protein-Losing Enteropathy
Although protein-losing enteropathy is a relatively uncommon complication after Fontan procedure, it remains difficult to both predict and to treat [33] . Protein-losing enteropathy is a common indication for cardiac transplantation, noted in approximately 40 % of patients transplanted for failed Fontan [6, 16] . Patients with proteinlosing enteropathy who have worse functional health status have increased mortality. Silvilairat et al. [35] reported a hazard ratio of 4.0 for time-related mortality for those patients with protein-losing enteropathy who were in NYHA class III or IV. The current study highlights a clinically important deterioration in physical functioning both in patients who had protein-losing enteropathy at baseline or who subsequently developed it during follow-up.
Limitations
The results of this study must be viewed in light of some limitations, most of which have been described in previous publications from Fontan 1 [24, 26] . These relate primarily to the representativeness of the cohort given that the denominator is not defined and that selection bias may be present. This may be magnified by drop-outs and exclusions for the current study.
The assessment of functional health status by parent or proxy report may be less valid, and we have previously documented differences from self-report [19] . We chose to use parent report to maintain consistency with the instrument used in Fontan 1 and to take advantage of the fact that the majority of Fontan 2 participants fell within the age range validated for the CHQ PF50. Given the paucity of data on longitudinal assessment with the CHQ, the responsiveness of the physical functioning summary score to changes in patient and medical characteristics is not known. The time frame of nearly 7 years between Fontan 1 and 2 may have been too short to observe meaningful changes in functional health status and medical conditions and thus may have influenced the detection of associations. Likewise, the age range at both time points may have placed the observation during a time period of stability, and greater changes may be observed during the transition into adulthood. Some of the changes in scores may have represented regression to the mean. However, adjustment in the association analyses for baseline score at Fontan 1 did not produce meaningful changes in findings. Meaningful associations may lie in the changes in laboratory testing measures over time, which were not assessed at Fontan 2 but will be the subject of future study.
Conclusions and Implications
We conclude that although adolescence may be a period of stability for many Fontan patients in terms of physical functioning, important deterioration occurs in some patients in association with the development of respiratory conditions and protein-losing enteropathy. Baseline laboratory measures appear to be poorly predictive of deterioration. Ongoing rigorous and longitudinal study of functional health status into adulthood is necessary to allow for a better understanding of the relationship between clinical morbidities and functional health status in this at risk group of patients with complex congenital heart disease.
